US Dato-DXd Approval Relief For AstraZeneca and Daiichi Sankyo

 
• By Alexandra Shimmings

The FDA green light for Datroway in breast cancer marks the first for a TROP2-directed antibody-drug conjugate and is a relief for partners AstraZeneca and Daiichi Sankyo after multiple filing mis-steps in its lung cancer indication.

Digital 3d illustration of cancer cells in human body
• Source: Shutterstock

More from Scrip

More from Immuno-oncology